… Such a strategy may have a significant impact on our future practice mainly due equivalent
… In the EURO-SKI trial, the largest study of TKI discontinuation, 114 821 patients with CML …

… diagnose and manage CML patients. Our recommendations focus on current best practice
… [48] but they are generally believed to be of no clinical significance, although one study did …

… Such a strategy may have a significant impact on our future practice mainly due … the study
at the European Hematology Association (EHA) 2022 annual meeting confirmed the persistent …

… chronic myeloid leukemia (CML) has profoundly changed over the past 7 years. Most patients
with chronic … In a phase II study of 73 newly diagnosed CP patients, the 10-year intention to …

… treatment goal or as a priority factor influencing treatment decisions. European Leukemia
Net … background information on the use of TKIs in clinical practice. The aims of the TARGET (…

Chronic myeloid leukemia (CML) is defined by the presence of Philadelphia chromosome (Ph)
which results from a reciprocal translocation between chromosomes 9 and 22 [t (9; 22] …

… treatment failure or ‘warning’, according to European LeukemiaNet (ELN) recommendations
6, 147 and may guide subsequent treatment … adopting this methodology as routine practice. …

… chronic myeloid leukemia (CML), juvenile myelomonocytic … of this approach in clinical practice:
false-negative results can … in myeloid neoplasms, and the recent European LeukemiaNet …

… Acute myeloid leukaemia (AML) incidence is age dependent, rising markedly in … the
European population may therefore contribute to the reported increase in AML incidence in Europe …

… In this review, we will summarize the diagnosis and treatment of AML … practices known to
be successful is challenging but can likely save more lives worldwide than any diagnostic study …